Started running Assaytools...
Skipping analysis of rows:  []
p38-Bosutinib Isomer-CD
MAP fitting cycle 5/5
Delta G (95% credibility interval after equilibration):
   -12.8 [-21.3,-10.5] k_B T
Delta G (mean and std after equil):
   -13.2 +- 2.81 k_B T
Kd (95% credibility interval after equilibration):
   2.8 [0.0,27.3] uM
Kd (mean and std after equil):
   1.8 uM +- 4807.0 uM
p38-Erlotinib-EF
MAP fitting cycle 5/5
Delta G (95% credibility interval after equilibration):
   -9.88 [-10.8,-8.55] k_B T
Delta G (mean and std after equil):
   -9.84 +- 0.577 k_B T
Kd (95% credibility interval after equilibration):
   51.0 [20.1,193.5] uM
Kd (mean and std after equil):
   53.5 uM +- 46.8 uM
p38-Gefitinib-GH
MAP fitting cycle 5/5
Delta G (95% credibility interval after equilibration):
   -13.5 [-14.2,-12.8] k_B T
Delta G (mean and std after equil):
   -13.5 +- 0.367 k_B T
Kd (95% credibility interval after equilibration):
   1.3 [0.7,2.8] uM
Kd (mean and std after equil):
   1.4 uM +- 0.6 uM
p38-Vandetanib_new-MN
MAP fitting cycle 5/5
Delta G (95% credibility interval after equilibration):
   -13.9 [-15.8,-12.5] k_B T
Delta G (mean and std after equil):
   -14 +- 1.12 k_B T
Kd (95% credibility interval after equilibration):
   913.8 [143.5,3555.2] nM
Kd (mean and std after equil):
   834.2 nM +- 975.7 nM
p38-Vandetanib_old-OP
MAP fitting cycle 5/5
Delta G (95% credibility interval after equilibration):
   -14.1 [-17.9,-12.7] k_B T
Delta G (mean and std after equil):
   -14.4 +- 2.1 k_B T
Kd (95% credibility interval after equilibration):
   768.7 [16.4,3178.6] nM
Kd (mean and std after equil):
   551.9 nM +- 860.3 nM
p38-Bosutinib-AB
MAP fitting cycle 5/5
Delta G (95% credibility interval after equilibration):
   -15 [-25,-13.7] k_B T
Delta G (mean and std after equil):
   -15.6 +- 2.65 k_B T
Kd (95% credibility interval after equilibration):
   302.1 [0.0,1129.3] nM
Kd (mean and std after equil):
   170.3 nM +- 298.4 nM
p38-Lapatinib-IJ
MAP fitting cycle 5/5
Delta G (95% credibility interval after equilibration):
   -9.4 [-10.9,-7.91] k_B T
Delta G (mean and std after equil):
   -9.4 +- 0.762 k_B T
Kd (95% credibility interval after equilibration):
   82.4 [18.8,367.6] uM
Kd (mean and std after equil):
   82.9 uM +- 102.0 uM
p38-Ponatinib-KL
MAP fitting cycle 5/5
Delta G (95% credibility interval after equilibration):
   -26 [-34.1,-17.3] k_B T
Delta G (mean and std after equil):
   -26 +- 5 k_B T
Kd (95% credibility interval after equilibration):
   5.1 [0.0,31330.5] pM
Kd (mean and std after equil):
   5.4 pM +- 13706.9 pM
Done.
